Targeted Modulation of Abundant Proteins Enhances Proteomic Profiling of Ovarian Cancer Ascites: A Pilot Technical Workflow Comparison
Journal of Proteome Research · 04.09.2026 · 25 (9) · 5011-5021
DOI: 10.1021/acs.jproteome.6c00382 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Proteome Research, online erschienen am 19.08.2026. Verfasst von Zongkai Peng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, The University of Oklahoma, Norman, Oklahoma73019, United States. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Proteomics, Ascites, Proteome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U.S. Department of Defense, NCI NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Ascites from ovarian cancer patients are increasingly recognized as a valuable biofluid for cancer research, as its protein composition reflects the disease state and may reveal biomarkers of treatment sensitivity and response. However, the detection of low-abundance proteins is hindered by the presence of highly abundant proteins such as albumin. In this study, we evaluated five protein preparation methods for their effectiveness in depleting high-abundance or enriching low-abundance proteins in ovarian cancer ascites. The Norgen (Nor), Minutes (Min), and Perchloric acid (PerCA) methods were based on abundant protein depletion, while the Urine (Uri) and Nanomics (Nano) kits focused on low-abundance protein enrichment. Processed samples were analyzed using label-free quantitative bottom-up proteomics by LC-MS/MS, followed by a bioinformatics assessment. Compared with undepleted ascites (UnD), Min, Nor, Nano, and PerCA increased protein identifications, whereas Uri produced profiles similar to those of UnD. Notably, PerCA and Nano enabled the identification of distinct protein subsets associated with cancer-related pathways, including immune responses and autophagy. PerCA enriched transmembrane and secreted immunomodulatory glycoproteins, whereas Nano enrichment primarily captured secreted, nuclear, and cytoplasmic soluble proteins. Overall, our results show that both high-abundance protein depletion and low-abundance enrichment improve ascites proteome coverage, each offering distinct advantages in identifying biologically relevant low-abundance proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, The University of Oklahoma, Norman, Oklahoma73019, United States.
- Department of Biochemistry and Physiology, University of Oklahoma Health Campus, Oklahoma City, Oklahoma73104, United States.
- Department of Pathology, University of Oklahoma Health Campus, Oklahoma City, Oklahoma73104, United States.
- Mass Spectrometry, Proteomics and Metabolomics Core Facility, Stephenson Life Sciences Research Center, University of Oklahoma, Norman, Oklahoma73019, United States.
ORCID-Profile: Doris M Benbrook, Zhibo Yang, Nagib Ahsan
Förderung
- U.S. Department of Defense
- NCI NIH HHS
- National Institute of Allergy and Infectious Diseases
- Division of Chemistry
- Ovarian Cancer Academy
- National Cancer Institute
Zitieren
APA
Peng, Z., Lausen, J., Benbrook, D. M., Yang, Z., & Ahsan, N. (2026). Targeted Modulation of Abundant Proteins Enhances Proteomic Profiling of Ovarian Cancer Ascites: A Pilot Technical Workflow Comparison. Journal of Proteome Research, 25(9), 5011-5021. https://doi.org/10.1021/acs.jproteome.6c00382
Vancouver
Peng Z, Lausen J, Benbrook DM, Yang Z, Ahsan N. Targeted Modulation of Abundant Proteins Enhances Proteomic Profiling of Ovarian Cancer Ascites: A Pilot Technical Workflow Comparison. Journal of Proteome Research. 2026;25(9):5011-5021. doi:10.1021/acs.jproteome.6c00382
BibTeX
@article{Peng2026,
author = {Peng, Zongkai and Lausen, James and Benbrook, Doris M and Yang, Zhibo and Ahsan, Nagib},
title = {Targeted Modulation of Abundant Proteins Enhances Proteomic Profiling of Ovarian Cancer Ascites: A Pilot Technical Workflow Comparison},
journal = {Journal of Proteome Research},
year = {2026},
volume = {25},
number = {9},
pages = {5011--5021},
doi = {10.1021/acs.jproteome.6c00382}
}
EUVIMED